全文获取类型
收费全文 | 23230篇 |
免费 | 1244篇 |
国内免费 | 172篇 |
专业分类
耳鼻咽喉 | 325篇 |
儿科学 | 422篇 |
妇产科学 | 539篇 |
基础医学 | 2745篇 |
口腔科学 | 753篇 |
临床医学 | 1844篇 |
内科学 | 6291篇 |
皮肤病学 | 406篇 |
神经病学 | 2300篇 |
特种医学 | 739篇 |
外科学 | 3445篇 |
综合类 | 84篇 |
一般理论 | 9篇 |
预防医学 | 1087篇 |
眼科学 | 309篇 |
药学 | 1531篇 |
1篇 | |
中国医学 | 42篇 |
肿瘤学 | 1774篇 |
出版年
2024年 | 19篇 |
2023年 | 158篇 |
2022年 | 342篇 |
2021年 | 664篇 |
2020年 | 384篇 |
2019年 | 552篇 |
2018年 | 637篇 |
2017年 | 474篇 |
2016年 | 562篇 |
2015年 | 603篇 |
2014年 | 914篇 |
2013年 | 1166篇 |
2012年 | 1800篇 |
2011年 | 1786篇 |
2010年 | 1062篇 |
2009年 | 941篇 |
2008年 | 1627篇 |
2007年 | 1557篇 |
2006年 | 1470篇 |
2005年 | 1477篇 |
2004年 | 1371篇 |
2003年 | 1249篇 |
2002年 | 1149篇 |
2001年 | 156篇 |
2000年 | 151篇 |
1999年 | 174篇 |
1998年 | 189篇 |
1997年 | 183篇 |
1996年 | 178篇 |
1995年 | 160篇 |
1994年 | 131篇 |
1993年 | 122篇 |
1992年 | 104篇 |
1991年 | 65篇 |
1990年 | 82篇 |
1989年 | 68篇 |
1988年 | 74篇 |
1987年 | 75篇 |
1986年 | 58篇 |
1985年 | 62篇 |
1984年 | 73篇 |
1983年 | 70篇 |
1982年 | 67篇 |
1981年 | 59篇 |
1980年 | 55篇 |
1979年 | 30篇 |
1978年 | 37篇 |
1977年 | 26篇 |
1976年 | 21篇 |
1975年 | 17篇 |
排序方式: 共有10000条查询结果,搜索用时 21 毫秒
101.
102.
103.
Percutaneous endoscopic lumbar discectomy (PELD) is a new technique for the decompression of the lumbar disc space and removal of nucleus pulposus via a posterolateral approach. The technique was introduced in Germany by the authors in April 1987. The method is indicated in patients with non-equestrated lumbar disc herniation with an intact lorsal longitudinal ligament. In local anesthesia, a working cannula (OD 5 mm) is placed at the dorsal lateral border of the disc. The disc space is opened with anulus trephines and the nucleus pulposus is removed with rigid and flexible forceps as well as with automated shaver systems under intermittent endoscopic control (discoscopy). The procedure is performed in local anesthesia. The results of the first thirty patients with a follow-up time between 6 months and 17 months could be graded as excellent in 13 cases, as good in 9 cases, as fair in 6 cases, and as bad in 2 cases. The relief of symptoms as judged by the patients was between 70–100 percent in the majority of the cases. Three patients had to be reoperated at the same level and site, because of either persistent or recurrent sciatica. The performance in local anesthesia, the atraumatic extraspinal approach, the reduced time of hospitalization and post-operative morbidity as well as the reduced time of work incapability are the main advantages of this new method. 相似文献
104.
Mario H. Vargas Luis M. Montaño Beatriz Vanda Patricia Segura Moisés Selman 《Naunyn-Schmiedeberg's archives of pharmacology》1990,342(3):278-283
Summary The allergic bronchoconstriction in guinea pigs has been attributed mainly to the release of mast cell mediators. Histamine has been involved in the first minutes of the anaphylactic reaction and new-formed compounds in the subsequent response. In this asthma model the vagal influence has been sparsely investigated. In the present work we evaluated the pharmacological modification of the acute allergic bronchoconstrictor response in guinea pigs sensitized to ovalbumin through aerosol exposure. Pyrilamine (20 g/kg), diethylcarbamazine (a lipoxygenase inhibitor, 10 mg/kg) and dexamethasone (4 mg/kg) each reduced the antigen-induced bronchoconstriction throughout the 30 min studied. Indomethacin (3.1 mg/kg) did not modify the response to the antigen. Atropine (2 mg/kg) plus bilateral vagotomy also diminished this response from 5 min onward. On the other hand, from 5 min ahead pyrilamine-resistant bronchoconstriction was partially inhibited by dexamethasone, and it was almost completely blocked during all of the response when atropine plus bilateral vagotomy were added to dexamethasone. Dipyridamole (an inhibitor of the adenosine uptake, 0.4 mg/kg) enhanced the bronchoconstriction, though this was significant only in the 2–5 min time-interval of the response. These results suggest that histamine and vagal influence play an important role in the whole response to antigen, that other mediators, probably leukotrienes, participate in this response from 5 min onward, and that adenosine could exert a potentiation effect on this response.
Send offprint requests to L. M. Montaño at the Instituto Nacional de Enfermedades Respiratorias 相似文献
105.
106.
107.
Friedrich Weber Carsten Kremer Mario Klinkhammer Bettina Rasier Mario Brock 《Journal of neuro-oncology》1994,18(3):217-224
Summary This publication describes a new model to investigate the influence of tumor necrosis factor- (TNF-) on a three-dimensional glial cell aggregate under defined, standardized, reproducible conditions using the glioma cell line A 172.The cells are initially grown as normal monolayer culture until they reach a cell density of up to 1×106. Subsequently they are grown as spheroids by the liquid overlay technique. Spheroids grown in this way were divided into ten groups of more than 50 cell aggregates. Three groups were coincubated with free TNF- in increasing dosages (100 ng/ml, 200 ng/ml and 1000 ng/ml); three groups were incubated with empty liposomes (0.2 mg/ml, 0.4 mg/ml and 2 mg/ml); three groups received liposomes which had been loaded with TNF-, and one group, which received no treatment, served as control.The diameter of the spheroids ranged from 80 m to 350 m. There was no significant difference in growth between the 3 groups treated with free TNF-. Comparing spheroids treated with TNF- with those which had been coincubated with empty liposomes, there was a significant difference (p<0.001) in growth, which correlated with the amount of liposomes. Similarly, free TNF- had a significantly (P<0.001) stronger growth-inhibiting effect as compared to liposomes loaded with TNF-. Comparing the groups treated with liposomes only to those treated with liposomes loaded with TNF-, the latter exhibited a more marked (although not significantly) growth-inhibiting effect.The preliminary conclusion is that the major growth-inhibiting effect seems to be mediated by the liposomes. This phenomenon is in agreement with results obtained in monolayer cultures. 相似文献
108.
Monica Campagnol M.D. Paolo Sapienza M.D. Filippo Napoli M.D. Mario Dauri M.D. Antonino Cavallaro M.D. F.A.C.S. F.I.C.A. 《The International journal of angiology》1995,4(4):193-197
Cultured, allogenic, human epidermal grafts have been successfully used to treat extensive burns, donor sites, leg ulcers, and eroded areas in recessive dystrophic epidermolysis bullosa. The following report describes the use of cryopreserved cultured human epidermal allografts in the treatment of long-standing ischemic ulcers unresponsive to conventional medical therapy in two patients who had previously undergone unsuccessful vascular reconstructive surgery. A marked reduction in ulcer size as well as rapid pain relief was achieved in both patients. In selected cases the use of epidermal grafts as a biologic topical therapy could represent an alternative to other medical treatments. However, thus far, only a few cases have been reported and the uncertain short- and long-term results as well as the excessive costs may limit the widespread application of this treatment modality. 相似文献
109.
110.
Dr. Maurizio Vaglini MD Dr. Filiberto Belli MD Mario Santinami MD Flavio Arienti MD Giorgio Parmiani MD Laura Persiani MD Nicola Santoro MD Maria Grazia Inglese MD Fortunato D'Elia MD Natale Cascinelli MD 《Annals of surgical oncology》1995,2(1):61-70
Background: Therapies of advanced melanoma patients with interleukin-2 (IL-2) and cytotoxic lymphocytes have produced interesting results, but a larger diffusion of these treatments is limited by the severe side effects due to IL-2 systemic infusion. A strictly regional administration of IL-2 and cells by an isolation perfusion (IP) in extracorporeal circulation (ECC) for the treatment of regional melanoma metastases could improve tolerability and efficacy of this specific modality of immunotherapy.
Methods: Ten patients were submitted to adoptive immunotherapy with IL-2 and lymphokine-activated killer (LAK) cells by IP in ECC. The schedule of treatment included the first course of a 5-day systemic administration of IL-2 (Proleukin, EuroCetus 9–12 × 106 IU/M2/day continuous infusion); autologous LAK cells were obtained via leukapheresis and after in vitro activation were given (range 8–28 × 109) along with IL-2 (120-2,400 IU/ml of perfusion priming) to the affected limb by IP; IL-2 (9–12×106 IU/m2/day) was also administered by systemic continuous infusion for 5 days starting on the day after IP.
Results: All patients concluded the treatment without any major local or systemic toxicities. Clinical responses included one complete and six partial remissions; three patients had stable disease. All patients are alive. Follow-up after IP ranged from 12 to 35 months (median: 22). The analysis of circulating lymphocytes revealed the rapid disappearance of LAK cells, suggesting their extravasation and/or endothelial adhesion in perfused tissues.
Conclusions: IP with IL-2 and LAK cells is a new approach for the treatment of in-transit metastases due to cutaneous melanoma. The treatment appears to be feasible and reliable. Further biological and immunological studies should permit amelioration of the present modality of treatment. 相似文献